Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ...

Billboard has announced an upcoming shift in its chart tabulation that will give more weight to music streaming against album ...

The biggest fitness trend of 2025 was simple — people chose routines that were easy, enjoyable, and stress-free. Strict diets and exhausting workout regimes took a backseat, while sustainable and ...

Spot & Tango reports on feeding puppies, highlighting age, breed size, and nutrient needs for proper growth and health.

The S&P 500 had a rough start to the week but finished on solid footing, ultimately finishing up 0.1% from last Friday. Read more here.

Lyor Cohen, the company's global head of music, argued that Billboard's formula for the charts doesn't put enough weight on ...

The video streaming giant blames the change, set to take effect in January, on a dispute over how non-subscriber streams are ...

The corporation announced that the shakeup reflects “an increase in streaming revenue and changing consumer behaviors.” Paid/subscription on-demand streams will now add more value than ad-supported on ...

Novo, however, vastly underestimated the appetite for its new weight-loss jab. Mr Doustdar says it planned for demand to be three times that of Saxenda, an older and less-effective weight-loss drug.

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push a new generation of obesity treatments while making sweeping changes to ...

The S&P 500 reached a new record high this week, crossing the 6,900 milestone for the first time ever. Read more here.

On Tuesday (Dec. 16), Billboard explained its latest changes to how rankings would be tabulated. In their words, the larger ...